Recombinant Human DCC Protein, CF Summary
Product Specifications
Phe32-Asn1097, with a C-terminal 6-His tag
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
8637-DC
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 400 μg/mL in PBS. |
Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: DCC
Deleted in Colorectal Cancer (DCC) was originally identified as a putative tumor suppressor gene that is down-regulated in more than 70% of colorectal cancers (1). DCC is a type I transmembrane glycoprotein that belongs to the immunoglobulin (Ig) superfamily (2, 3). It contains an extracellular domain (ECD) composed of four Ig-like domains and six fibronectin type III repeats, a transmembrane region, and a cytoplasmic domain (1, 4-6). The ECD of human DCC shares 97% amino acid sequence identity with mouse and rat DCC. In adults, DCC is expressed most abundantly in brain tissue, but it is also expressed at low levels in multiple other tissues (4, 6). DCC is a receptor for Netrin-1 and is important for dopaminergic neuronal precursor migration, axon guidance, and axon arborization (2, 7-10). Binding of DCC by Draxin, at a site distinct from the Netrin-1 binding site, results in the inhibition of neurite outgrowth (11). Signaling downstream of DCC may also be required for the confinement of central axons to the central nervous system (12). DCC regulates apoptosis as a dependence receptor and induces apoptosis in the absence of Netrin-1 binding (13-15). DCC has been shown to inhibit metastasis, and loss of DCC’s apoptotic activity promotes tumorigenesis in mice, providing in vivo evidence that DCC is a tumor suppressor gene (16-18).
- Fearon, E.R. et al. (1990) Science 247:49.
- Keino-Masu, K. et al. (1996) Cell 87:175.
- Arakawa, H. (2004) Nat. Rev. Cancer 4:978.
- Hedrick, L. et al. (1994) Genes Dev. 8:1174.
- Vielmetter, J. et al. (1994) J. Cell Biol. 127:2009.
- Reale, M.A. et al. (1994) Cancer Res. 54:4493.
- Hong, K. et al. (1999) Cell 97:927.
- Forcet, C. et al. (2002) Nature 417:443.
- Xu, B. et al. (2010) Neuroscience 169:932.
- Zhang, C. et al. (2012) J. Neurosci. 32:12589.
- Ahmed, G. et al. (2011) J. Neurosci. 31:14018.
- Laumonnerie, C. et al. (2014) Development 141:594.
- Mehlen, P. et al. (1998) Nature 395:801.
- Chen, Y.Q. et al. (1999) Oncogene 18:2747.
- Furne, C. et al. (2008) Proc. Natl. Acad. Sci. USA 105:14465.
- Rodrigues, S. et al. (2007) Oncogene 26:5615.
- Krimpenfort, P. et al. (2012) Nature 482:538.
- Castets, M. et al. (2011) Nature 482:534.
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human DCC Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human DCC Protein, CF and earn rewards!
Have you used Recombinant Human DCC Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image